Home
EW
EW News

Latest Edwards Lifesciences Corporation (EW) News on March 31, 2025

Jim Cramer Calls Edwards Lifesciences (EW) a Hold – Prefers Boston Scientific Right Now!

Insider Monkey

6 hours ago

Jim Cramer Calls Edwards Lifesciences (EW) a Hold – Prefers Boston Scientific Right Now!

MT Newswires

4 days ago

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $85 From $92, Keeps Buy Rating

Argus Research

6 days ago

EW: Raising target price to $75.00

Medtronic’s Evolut trial outcome could shift US TAVR market

Medical Device Network

11 days ago

Medtronic’s Evolut trial outcome could shift US TAVR market

Morningstar Research

21 days ago

Analyst Report: Edwards Lifesciences Corporation

Edwards Lifesciences Corporation (EW): Among the Top Stocks to Buy According to Citadel Investment Group

Insider Monkey

21 days ago

Edwards Lifesciences Corporation (EW): Among the Top Stocks to Buy According to Citadel Investment Group

Edwards Lifesciences Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a month ago

Edwards Lifesciences Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Argus Research

a month ago

EW: Lowering target price to $63.00

Argus Research

a month ago

EW: Lowering target price to $64.00

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference

Business Wire

a month ago

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference

Should Edwards Lifesciences Stock Remain in Your Portfolio Now?

Zacks

a month ago

Should Edwards Lifesciences Stock Remain in Your Portfolio Now?

Argus Research

a month ago

EW: Raising target price to $67.00

The three-year loss for Edwards Lifesciences (NYSE:EW) shareholders likely driven by its shrinking earnings

Simply Wall St.

a month ago

The three-year loss for Edwards Lifesciences (NYSE:EW) shareholders likely driven by its shrinking earnings

MT Newswires

2 months ago

Canaccord Genuity Adjusts Price Target on Edwards Lifesciences to $71 From $68, Maintains Hold Rating

MT Newswires

2 months ago

Daiwa Adjusts Price Target on Edwards Lifesciences to $77 From $72, Maintains Neutral Rating

Morningstar Research

2 months ago

Analyst Report: Edwards Lifesciences Corporation

Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion

Investor's Business Daily

2 months ago

Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength

Benzinga

2 months ago

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Edwards Lifesciences Corp Earnings Call

Is Edwards Lifesciences Corporation (EW) the Best Medical Device Stock to Buy?

Insider Monkey

2 months ago

Is Edwards Lifesciences Corporation (EW) the Best Medical Device Stock to Buy?

MT Newswires

2 months ago

Evercore ISI Adjusts Price Target on Edwards Lifesciences to $73 From $75, Keeps In Line Rating

MT Newswires

2 months ago

Wolfe Research Adjusts Price Target on Edwards Lifesciences to $61 From $60, Keeps Underperform Rating

MT Newswires

2 months ago

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $92 From $90, Keeps Buy Rating

MT Newswires

2 months ago

Morgan Stanley Adjusts Price Target on Edwards Lifesciences to $75 From $70, Keeps Equalweight Rating

MT Newswires

2 months ago

Bernstein Adjusts Price Target on Edwards Lifesciences to $78 From $74, Keeps Market Perform Rating

MT Newswires

2 months ago

JPMorgan Adjusts Price Target on Edwards Lifesciences to $80 From $78, Keeps Neutral Rating

Edwards Lifesciences (EW) Reports Q4: Everything You Need To Know Ahead Of Earnings

StockStory

2 months ago

Edwards Lifesciences (EW) Reports Q4: Everything You Need To Know Ahead Of Earnings

Edwards Lifesciences Corporation (NYSE:EW) is a favorite amongst institutional investors who own 88%

Simply Wall St.

2 months ago

Edwards Lifesciences Corporation (NYSE:EW) is a favorite amongst institutional investors who own 88%

Mettler-Toledo (MTD) Surpasses Q4 Earnings and Revenue Estimates

Zacks

2 months ago

Mettler-Toledo (MTD) Surpasses Q4 Earnings and Revenue Estimates

DexCom (DXCM) Q4 Earnings Preview: What's in the Cards?

Zacks

2 months ago

DexCom (DXCM) Q4 Earnings Preview: What's in the Cards?

Insights Into Edwards Lifesciences (EW) Q4: Wall Street Projections for Key Metrics

Zacks

2 months ago

Insights Into Edwards Lifesciences (EW) Q4: Wall Street Projections for Key Metrics

Argus Research

2 months ago

EW: Lowering target price to $63.00

ITGR or EW: Which Is the Better Value Stock Right Now?

Zacks

2 months ago

ITGR or EW: Which Is the Better Value Stock Right Now?

Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025

Business Wire

2 months ago

Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025

Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Simply Wall St.

2 months ago

Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences Corporation (EW): A Bull Case Theory

Insider Monkey

2 months ago

Edwards Lifesciences Corporation (EW): A Bull Case Theory

Top Analyst Reports for Alibaba, Airbnb & Royal Caribbean Cruises

Zacks

2 months ago

Top Analyst Reports for Alibaba, Airbnb & Royal Caribbean Cruises

Benzinga

2 months ago

Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion

Edwards Lifesciences Q4 Earnings Set to Benefit From TAVR Growth

Zacks

2 months ago

Edwards Lifesciences Q4 Earnings Set to Benefit From TAVR Growth

MT Newswires

2 months ago

Stifel Upgrades Edwards Lifesciences to Buy From Hold, Adjusts Price Target to $90 From $75

Argus Research

2 months ago

EW: Raising target price to $64.00

Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for

Zacks

2 months ago

Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for

What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?

Simply Wall St.

2 months ago

What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?

Argus Research

2 months ago

EW: Lowering target price to $63.00

Masimo Taps Katie Szyman as Permanent CEO

The Wall Street Journal

2 months ago

Masimo Taps Katie Szyman as Permanent CEO

MT Newswires

2 months ago

Edwards Lifesciences Insider Sold Shares Worth $343,736, According to a Recent SEC Filing

MT Newswires

2 months ago

Edwards Lifesciences Shares Fall After Downgrade From Wolfe Research

Declining Stock and Solid Fundamentals: Is The Market Wrong About Edwards Lifesciences Corporation (NYSE:EW)?

Simply Wall St.

2 months ago

Declining Stock and Solid Fundamentals: Is The Market Wrong About Edwards Lifesciences Corporation (NYSE:EW)?

Do You Believe in the Growth Prospects of Edwards Lifesciences Corporation (EW)?

Insider Monkey

2 months ago

Do You Believe in the Growth Prospects of Edwards Lifesciences Corporation (EW)?

Should Edwards Lifesciences Stock Stay in Your Portfolio Now?

Zacks

2 months ago

Should Edwards Lifesciences Stock Stay in Your Portfolio Now?

MT Newswires

2 months ago

Wolfe Research Downgrades Edwards Lifesciences to Underperform From Peer Perform, Price Target is $60

Undervalued Small Caps With Insider Action In January 2025

Simply Wall St.

2 months ago

Undervalued Small Caps With Insider Action In January 2025

Argus Research

3 months ago

EW: What does Argus have to say about EW?

MT Newswires

3 months ago

Pulse Biosciences Names Paul LaViolette CEO

MT Newswires

3 months ago

Bernstein Adjusts Price Target on Edwards Lifesciences to $74 From $72, Keeps Market Perform Rating

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Business Wire

3 months ago

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE:EW) is largely controlled by institutional shareholders who own 85% of the company

Simply Wall St.

3 months ago

Edwards Lifesciences Corporation (NYSE:EW) is largely controlled by institutional shareholders who own 85% of the company

Edwards Lifesciences price target raised to $75 from $69 at Evercore ISI

TipRanks

3 months ago

Edwards Lifesciences price target raised to $75 from $69 at Evercore ISI

MT Newswires

3 months ago

Evercore ISI Adjusts Price Target on Edwards Lifesciences to $75 From $69

Top 10 medtech deals of 2024

MedTech Dive

3 months ago

Top 10 medtech deals of 2024

Edwards Lifesciences Corporation (EW): Among the Cheap Healthcare Stocks to Buy Heading Into 2025

Insider Monkey

3 months ago

Edwards Lifesciences Corporation (EW): Among the Cheap Healthcare Stocks to Buy Heading Into 2025

A Look At The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Simply Wall St.

3 months ago

A Look At The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Argus Research

3 months ago

EW: What does Argus have to say about EW?

DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock?

Zacks

3 months ago

DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock?

Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback?

Insider Monkey

3 months ago

Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback?

Is the Options Market Predicting a Spike in Edwards (EW) Stock?

Zacks

3 months ago

Is the Options Market Predicting a Spike in Edwards (EW) Stock?

CMS proposes Medicare coverage for transcatheter tricuspid replacement

MedTech Dive

3 months ago

CMS proposes Medicare coverage for transcatheter tricuspid replacement

MT Newswires

3 months ago

Baird Adjusts Edwards Lifesciences Price Target to $70 From $68, Maintains Neutral Rating

Undervalued Small Caps With Insider Action To Watch In December 2024

Simply Wall St.

3 months ago

Undervalued Small Caps With Insider Action To Watch In December 2024

Argus Research

3 months ago

EW: Raising target price to $65.00

MT Newswires

3 months ago

BofA Securities Upgrades Edwards Lifesciences to Buy From Neutral, Price Target is $90

Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?

Zacks

4 months ago

Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?

Capstan Medical raises $110M for heart valve with robotic system

MedTech Dive

4 months ago

Capstan Medical raises $110M for heart valve with robotic system

MT Newswires

4 months ago

Citigroup Adjusts Price Target on Edwards Lifesciences to $83 From $81, Keeps Buy Rating

Argus Research

4 months ago

EW: Raising target price to $64.00

MT Newswires

4 months ago

Edwards Lifesciences Insider Sold Shares Worth $358,751, According to a Recent SEC Filing

MT Newswires

4 months ago

Edwards Lifesciences Insider Sold Shares Worth $806,406, According to a Recent SEC Filing

Be Wary Of Edwards Lifesciences (NYSE:EW) And Its Returns On Capital

Simply Wall St.

4 months ago

Be Wary Of Edwards Lifesciences (NYSE:EW) And Its Returns On Capital

Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?

Zacks

4 months ago

Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?

MT Newswires

4 months ago

Redburn Adjusts Price Target on Edwards Lifesciences to $81 From $80

MT Newswires

4 months ago

Bernstein Adjusts Price Target on Edwards Lifesciences to $72 From $71

MT Newswires

4 months ago

UBS Adjusts Price Target on Edwards Lifesciences to $78 From $75, Keeps Neutral Rating

Edwards expects new TAVR approval in mid-2025 to boost sales

MedTech Dive

4 months ago

Edwards expects new TAVR approval in mid-2025 to boost sales

MT Newswires

4 months ago

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $90 From $81, Keeps Buy Rating

MT Newswires

4 months ago

Canaccord Genuity Adjusts Price Target on Edwards Lifesciences to $68 From $63, Keeps Hold Rating

MT Newswires

4 months ago

Truist Securities Adjusts Price Target on Edwards Lifesciences to $78 From $70, Keeps Hold Rating

MT Newswires

4 months ago

Stifel Adjusts Price Target on Edwards Lifesciences to $75 From $70, Keeps Hold Rating

MT Newswires

4 months ago

TD Cowen Adjusts Price Target on Edwards Lifesciences to $75 From $70, Keeps Hold Rating

MT Newswires

4 months ago

Leerink Partners Adjusts Price Target on Edwards Lifesciences to $77 From $74, Keeps Market Perform Rating

MT Newswires

4 months ago

RBC Capital Adjusts Price Target on Edwards Lifesciences to $85 From $80, Keeps Outperform Rating

Morningstar Research

4 months ago

Analyst Report: Edwards Lifesciences Corporation

Edwards Lifesciences Outlines Vision For Growth At Investor Conference

Benzinga

4 months ago

Edwards Lifesciences Outlines Vision For Growth At Investor Conference

MT Newswires

4 months ago

Leerink Adjusts Price Target on Edwards Lifesciences to $74 From $73

MT Newswires

4 months ago

Edwards Lifesciences Provides 2025 Guidance

Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

Business Wire

4 months ago

Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference

Argus Research

4 months ago

EW: Lowering target price to $63.00

MT Newswires

4 months ago

Barclays Adjusts Price Target on Edwards Lifesciences to $88 From $85

Edwards Lifesciences Corporation's (NYSE:EW) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Simply Wall St.

4 months ago

Edwards Lifesciences Corporation's (NYSE:EW) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

New Evidence on SAPIEN 3 Ultra RESILIA Valve Set to Boost EW Stock

Zacks

4 months ago

New Evidence on SAPIEN 3 Ultra RESILIA Valve Set to Boost EW Stock

MT Newswires

4 months ago

RBC Raises Price Target on Edwards Lifesciences to $80 From $75, Keeps Outperform Rating

Share on Social Networks: